These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 191529)

  • 1. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
    Gooding LR
    J Immunol; 1977 Mar; 118(3):920-7. PubMed ID: 191529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblasts.
    Warnatz H; Krapf F
    J Immunol; 1976 Sep; 117(3):981-5. PubMed ID: 182884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificities of killing by T lymphocytes generated against syngeneic SV40 transformants: studies employing recombinants within the H-2 complex.
    Gooding LR
    J Immunol; 1979 Mar; 122(3):1002-8. PubMed ID: 87414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.
    Gooding LR; Edwards CB
    J Immunol; 1980 Mar; 124(3):1258-62. PubMed ID: 6244348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of cytotoxic lymphocytes by SV40-induced antigens.
    Chang C; Chang R; Mora PT; Hu CP
    J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
    Chapes SK; Gooding LR
    J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of nonspecific killer cells by interleukin 2-containing supernatants.
    Teh HS; Yu M
    J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring cell-mediated cytotoxicity against simian virus 40-transformed 3T3 murine tumor cells.
    Kanar MC; Winkelstein A; Platt D
    J Natl Cancer Inst; 1983 Feb; 70(2):267-73. PubMed ID: 6296520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between subpopulations of normal mouse spleen cells in the in vitro generation of cell-mediated cytotoxicity specific for "modified self" antigens.
    Hodes RJ; Hathcock KS; Shearer GM
    J Immunol; 1975 Oct; 115(4):1122-5. PubMed ID: 51877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus specific antigens in BK virus-transformed cells detected by cell-mediated immune reactions.
    Karjalainen HE; Laaksonen AM; Mäntyjärvi RA
    Med Biol; 1983 Feb; 61(1):73-8. PubMed ID: 6302408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody blockade of lysis by T lymphocyte effectors generated against syngeneic SV40 transformed cells.
    Gooding LR
    J Immunol; 1979 Jun; 122(6):2328-36. PubMed ID: 221583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyt phenotype of H-2b CTL effectors and precursors specific for the SV40 transplantation rejection antigen.
    Flyer DC; Anderson RW; Tevethia SS
    J Immunol; 1982 Dec; 129(6):2368-71. PubMed ID: 6292288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor growth mediated by lymphocytes sensitized in vitro to a syngeneic murine teratocarcinoma 402AX.
    Bartlett PF; Fenderson BA; Edidin M
    J Immunol; 1978 Apr; 120(4):1211-7. PubMed ID: 641346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
    Wong CY; Woodruff JJ; Woodruff JF
    J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
    Koren HS; Hodes RJ
    Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Destruction of experimental malignant melanoma by mediators of cellular immunity.
    Youdim S
    Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
    Koszinowski U; Thomssen R
    Eur J Immunol; 1975 Apr; 5(4):245-51. PubMed ID: 1086229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.